Resource Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$651K Buy
976
+17
+2% +$10.6K 0.07% 87
2021
Q3
$548K Buy
959
+15
+2% +$8.23K 0.06% 97
2021
Q2
$476K Sell
944
-700
-43% -$330K 0.05% 106
2021
Q1
$750K Hold
1,644
0.09% 78
2020
Q4
$766K Buy
1,644
+199
+14% +$93.3K 0.1% 71
2020
Q3
$638K Buy
1,445
+100
+7% +$41.3K 0.1% 72
2020
Q2
$487K Hold
1,345
0.08% 78
2020
Q1
$381K Sell
1,345
-50
-4% -$15.8K 0.08% 86
2019
Q4
$453K Hold
1,395
0.07% 88
2019
Q3
$406K Hold
1,395
0.07% 93
2019
Q2
$410K Hold
1,395
0.07% 91
2019
Q1
$382K Hold
1,395
0.07% 97
2018
Q4
$312K Hold
1,395
0.07% 97
2018
Q3
$340K Buy
1,395
+181
+15% +$41.6K 0.06% 99
2018
Q2
$251K Hold
1,214
0.05% 114
2018
Q1
$251K Hold
1,214
0.05% 108
2017
Q4
$247K Buy
+1,214
New +$233K 0.05% 115

Other funds holding TMO

Resource Management's TMO Position: Q4 2021 in Review

Resource Management increased its Thermo Fisher Scientific (TMO) stake by 1.8% in Q4 2021, buying an estimated $10.6K and bringing the position to 976 shares worth $651K. The position accounts for 0.07% of the portfolio, ranked #87.

Resource Management first reported a position in TMO in Q4 2017 and has held it in 17 quarters since. The position peaked at $766K in Q4 2020. 2,343 funds tracked by Wall St. Rank hold TMO as of Q4 2021.

  • Resource Management held 976 shares of Thermo Fisher Scientific worth $651K as of Q4 2021.
  • Resource Management bought 17 Thermo Fisher Scientific shares in Q4 2021, an estimated $10.6K.
  • Thermo Fisher Scientific made up 0.07% of Resource Management's portfolio in Q4 2021, its #87 holding.
  • Resource Management first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 17 quarters since.
  • Resource Management's Thermo Fisher Scientific position peaked at $766K in Q4 2020.
  • 2,343 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2021.

Based on Resource Management's 13F filing for Q4 2021, filed 14 Feb 2022.